| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medical Psychology (S.E., M.S.) and Division of Endocrinology, Department of Medicine (S.H., D.K., K.M., O.E.J.), University of Essen, 45122 Essen, Germany; and Division of Angiology, Department of Medicine (A.H.Ö.), Hospital Schwabing, 80804 Munich, Germany
Address all correspondence and requests for reprints to: Onno E. Janssen, M.D., Division of Endocrinology, Department of Medicine, University of Essen, Hufelandstr. 55, 45122 Essen, Germany. E-mail: onno.janssen{at}uni-essen.de.
 |
Abstract |
|---|
 Top Abstract IntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
|
Introduction |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
Many aspects of the disorder can very conceivably cause a significant amount of emotional stress (12). Changes in appearance, irregular or absent menstrual periods, difficulties conceiving, and possibly disturbances in sexual attitudes and behavior can result in psychological distress and may also influence the feminine identity of patients with PCOS (13). Accumulating evidence on the long-term health risks associated with PCOS (e.g. diabetes mellitus) may also have a negative impact on psychosocial well-being. Indeed, the diagnosis of PCOS has been found to be associated with feelings of frustration and anxiety (14). In adolescents with PCOS, a negative impact on various aspects of health-related quality of life (HRQL), including limitations in physical functioning, general behavior, and family activities, has been found (15). In 1998 a self-administrated quality-of-life-questionnaire (PCOSQ) for women with PCOS was published by Cronin et al. (16), but results of its use have not been published. We now present an investigation of the impact of PCOS on psychosocial and emotional functioning, HRQL, and sexual satisfaction in a German patient sample compared with an age-matched healthy control sample.
|
Subjects and Methods |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
Patients were recruited from the outpatient clinics of the Division of Endocrinology, Department of Medicine at the University of Essen, based on referrals from gynecologists in the surrounding area or patients attracted by the clinic’s home page. Based on the criteria derived from the 1990 National Institutes of Health conference (3), diagnosis of PCOS was established when either oligomenorrhea (cycles lasting longer than 35 d) or amenorrhea (absence of menstrual cycles in the past 6 months) and either clinical signs of hyperandrogenism [hirsutism with a Ferriman/Gallwey score of more than 7 (17) or obvious acne] or an elevated total testosterone (normal range < 2.0 nmol/liter) were found, and other pituitary, adrenal, or ovarian diseases could be excluded. All recruited women were required to be otherwise healthy. Age-matched healthy controls were recruited from a health screening program for employees instituted at the University of Essen. Exclusion criteria for controls included any known medical condition or psychological disorder, irregular periods, or hormonal disturbances. This was verified by personal interview, physical examination, and measurement of hormone parameters including LH, FSH, estradiol, total testosterone, TSH, free T4, and cortisol. All hormone parameters were determined on an automated chemiluminescence assay system (Centaur, Bayer Vital, Fernwald, Germany) with an intraassay variation of less than 5% and an interassay variation of less than 8%. The study protocol was approved by the Ethics Committee of the University of Essen. All participants gave written informed consent before entering the study, and all questionnaires were made anonymous before evaluation.
Instruments and measures
Quality of life, psychosocial well-being, and sexuality of patients with PCOS and controls were assessed with three standardized, validated questionnaires: Psychological disturbances were assessed with the German version of the symptom checklist revised (SCL-90-R) (18), which quantifies psychological distress on the dimensions of somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, aggression, phobia, paranoid ideation, and psychoticism as well as on three global scales, namely the Global Severity Index (GSI), the Positive Symptom Distress Index (PSDI), and the Positive Symptom Total (PST) (19). HRQL was assessed with the German version of the 36-item short-form health survey (SF-36) (20). This widely used and validated instrument contains a total of eight subscales, namely physical function, physical role function, bodily pain, general health, vitality, social function, emotional role function, and mental health (21, 22). Summed data from the subscales are transformed into a 0- to 100-point scale. In addition, the subscales are combined to yield physical function and mental health as two summary health status measures. Subjects further completed the Fragebogen zur Lebenszufriedenheit (questions on life satisfaction) (FLZ), which is a questionnaire assessing satisfaction with various aspects of life on a total of 10 scales, namely health, work and profession, finances, leisure activities, marriage and relationship, relationship to children, self, sexuality, friends and relatives, and living conditions (23, 24). However, the scale relationship to children was omitted from analyses because only a small proportion of participants had children.
In addition to these standardized instruments, a questionnaire was constructed addressing several PCOS-specific issues: On a five-point rating scale (not at all, a little, average, more than average, and very much), participants rated the impact of excess body hair, obesity, and infertility. On the same scale, they rated their satisfaction with outer appearance. Sexual satisfaction was assessed using a 100-mm visual analog scale (VAS) ranging from not at all at the 0-mm mark to very much at the 100-mm mark. Included were items regarding the impact of hirsutism on sexuality and the ability to make social contacts, the importance of a satisfying sex life, own satisfaction with their sex life during the past month, satisfaction of the partner with their sex life, sexual thoughts and fantasies during the past month, frequency of pain during sexual intercourse, the feeling of being sexually attractive, and the feeling that their partner finds them sexually attractive. Women were instructed to place a mark at the point that best corresponded with their feelings. In this context, there were also items documenting the partnership situation of the subjects, including information about marital status as well as number and duration of relationships. The frequency of sexual intercourse during the past month was also recorded. All patients completed the questionnaires without linguistic or cognitive difficulties.
Data analysis
The SCL-90-R, SF-36, and FLZ were scored and analyzed according to the published guidelines (18, 20, 23). For VAS scales, the distance from 0 mm to the patient’s mark was measured. For statistical comparisons of the two groups, independent-samples Student’s t tests were computed using the Statistical Package for the Social Sciences (SPSS, Inc., Chicago, IL) statistical software package (25). To take the effect of body weight into account, secondary covariance analyses with body mass index (BMI) as the covariate were carried out. For group comparisons of sociodemographic sample characteristics, Fisher’s exact tests for analysis of frequency distributions was used. Pearson’s r was computed for correlations. The 
-level for statistical significance was set at 0.05. In the initial analysis, no adjustments were made for multiple comparisons, but the effect of -correction using Bonferroni’s method to control for type I error is indicated. Here, a more conservative -level was applied, which was calculated based on the number of scales in each questionnaire (i.e. rather than applying an alpha of 0.05 for accepting statistical significance, 0.05 was divided by the number of scales in each questionnaire) (26). Data are presented as mean ± SD.
|
Results |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
A total of 50 women with PCOS and 50 aged-matched, healthy women were recruited. The majority of patients with PCOS were referred to our clinic by their gynecologist. A few patients with PCOS initiated contact based on information posted on the clinic’s home page. Patients with PCOS and healthy controls did not differ in sociodemographic variables, including age, family status, education, and employment (Table 1
). In addition, the majority of individuals in both groups did not smoke, drank alcohol infrequently, and rated their general health as being good or very good. Fifty-four percent of patients with PCOS (controls 32%) were clinically obese (BMI 
25 kg/m2), corresponding to an elevated mean BMI of 30.1 ± 9.8 in affected women (controls 24.4 ± 5.4). Furthermore, a significantly greater proportion of patients with PCOS reported to currently have an unfulfilled wish to conceive a child (PCOS 42%, controls 6%). This difference was very likely to be related to a selection bias/self-selection for specialized medical treatment because 30% of patients were referred specifically because of infertility problems, and almost all patients had previously been diagnosed with PCOS and thus aware of potential infertility problems. The diagnosis of PCOS had been established an average of 37.9 ± 47.0 months before the patients took the survey. As expected, parameters characteristic for PCOS were elevated in affected women, with a mean hirsutism score (17) of 12 ± 5 (controls 3 ± 2), a mean LH:FSH ratio of 2.7 ± 1.2 (controls 1.3 ± 0.6), and a mean serum testosterone of 2.7 ± 0.9 nmol/liter (controls 1.1 ± 0.6).
|
HRQL, life satisfaction, and psychological disturbances in patients with PCOS and healthy controls were evaluated with a survey containing general questions on PCOS-specific issues and three standardized questionnaires (SCL-90-R, SF-36, and FLZ). Patients with PCOS reported that the disorder negatively affected various aspects of their life, including family life (40.0%), professional activities (27.5%), leisure activities (29.5%), and physical fitness (23.6%).
Evaluation of psychological disturbances with the SCL-90-R revealed significantly higher scores on the dimensions of obsessive-compulsive, interpersonal sensitivity, depression, aggression, and psychoticism in patients with PCOS (Fig. 1), whereas healthy controls scored within the normative population means for all scales. Accordingly, patients’ scores were significantly elevated on two of the questionnaire’s three global indices, namely the GSI [PCOS 0.72 ± 0.65; controls 0.42 ± 0.44 (mean ± SD; P < 0.01)] and the PSDI [PCOS 1.6 ± 0.64; controls 1.3 ± 0.37 (mean ± SD; P < 0.05)], corresponding to an increase in patients with PCOS by about 1 SD above the norms’ means for all scales as well as for the global indices. Following alpha adjustment for multiple comparisons according to the conservative Bonferroni method (corrected alpha for accepting statistical significance: 0.05/12 = 0.0042), group differences in the dimensions of obsessive-compulsive (P < 0.002), interpersonal sensitivity (P < 0.002), and depression (P < 0.002) remained statistically significant.
|
). In contrast, no significant differences were found for the scales of physical function and general health. Based on a corrected alpha for multiple comparisons (adjusted alpha for accepting statistical significance: 0.05/8 = 0.0063), group comparisons remained significant for physical role function (P < 0.003), vitality (P < 0.0001), emotional role function (P < 0.0001), and mental health (P < 0.0001).
|
). In contrast, the patient and control groups did not differ significantly in the scales of work and profession, finances, leisure activities, marriage and relationship, friends and relatives, and living conditions. The alpha adjustment for multiple comparisons (adjusted alpha: 0.05/9 = 0.0056) did not affect the FLZ questionnaire results because all comparisons had an alpha level of P < 0.001.
|
As one important area of quality of life, sexual satisfaction was assessed in patients and controls with a questionnaire using VASs (Table 2). The majority of women in both groups currently had a sexual partner (patients: 66%, controls: 76%), with similar numbers of patients and controls being married (42% vs. 38%) or single (46% vs. 54%). Patients with PCOS and controls did not differ in the frequency of sexual intercourse or sexual thoughts and fantasies during the past month (Table 2). In addition, the groups rated a satisfying sex life as equally important. However, women with PCOS were significantly less satisfied with their sex life and found themselves significantly less sexually attractive. Responses regarding sexual satisfaction and the feeling of being sexually attractive were significantly correlated in both patients with PCOS (r = 0.51, P < 0.001) and controls (r = 0.63, P < 0.001). Compared with the healthy control women, patients with PCOS further felt that their partners were significantly less satisfied with their sex life and that their partner found them significantly less sexually attractive. Finally, women with PCOS believed to a significantly greater extent than controls that their excessive body hair negatively affects their sexuality and that their outer appearance makes it difficult to form social contacts (Table 2). Using an adjusted alpha level to control for inflation of type I error (adjusted P 0.05/9 = 0.056) did not affect the reported results (all P < 0.001) except for the VAS scales addressing the partners’ assessment of sexual attraction (P < 0.02) and the impact of outer appearance on the difficulties to form social contacts (P < 0.05).
|
To take the potentially confounding effects of obesity into account, secondary covariance analyses were carried out using BMI as the covariate. Having controlled for group differences in obesity with this procedure, the following group comparisons remained statistically significant: Patients with PCOS reported significantly lower HRQL, measured with the SF-36, on the scales of physical role function (P < 0.01), vitality (P < 0.01), emotional role function (P < 0.001), and mental health (P < 0.05). In the FLZ life satisfaction questionnaire, patients demonstrated significantly lower satisfaction in the areas of health (P < 0.05), self (P < 0.01), and sex (P < 0.01). With regard to psychological disturbances, measured with the SCL-90-R, patients had significantly higher scores, indicating greater disturbances, in the dimensions of obsessive-compulsive (P < 0.05), interpersonal sensitivity (P < 0.05), depression (P < 0.05), and psychoticism (P < 0.05). However, after controlling for BMI, no differences between groups were found for the SCL-90-R’s three global indices (i.e. the GSI, PSDI, PST).
In contrast, BMI had no impact on the VASs addressing sexual satisfaction: Both obese and nonobese women with PCOS reported being significantly less satisfied with their sex life in the past month (P < 0.001), finding themselves significantly less sexually attractive (P < 0.05), believing their partner to be significantly less satisfied with their sex life (P < 0.001), and reporting that excessive body hair affected their sexuality (P < 0.001). BMI also had no significant effect on the frequency of sexual intercourse or sexual thoughts and fantasies.
|
Discussion |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
Although an early study on married women coping with infertility using the Institute for Personality and Ability Testing (IPAT) Anxiety Scale, the IPAT Depression Scale, the Tennessee Self-Concept Scale, and the Internal-External Scale found no emotional maladjustment (28), recent studies on adolescent girls with PCOS using the Child Health Questionnaire-Child Self-Report Form reported a 3.4 times increased concern about their ability to become pregnant (29). Girls with PCOS also had a 2.8 times reduced likelihood to have sexual intercourse than healthy subjects, although the mean age at initiation of sexual intercourse among sexually active girls was not significantly different between the two groups, and the severity of PCOS and the worry about fertility were not associated with odds of being sexually active (29). Furthermore, limitations in general health perceptions, physical functioning, general behavior, and family activities have been found in adolescents with PCOS (15). Two case report studies have reported an association of an increased psychiatric morbidity in patients with PCOS, implying an etiology of monoamine imbalances (30) or elevations of LH and androgens (31) because monoamine oxidase inhibitor antidepressants and clomiphene citrate, respectively, ameliorated the psychiatric illness.
We have now evaluated HRQL, life satisfaction, and sexuality in adult patients with PCOS with a comprehensive combination of standardized questionnaires and a collection of questions designed to specifically evaluate characteristics of PCOS. The comparison of healthy controls and patients with PCOS revealed no differences in sociodemographic variables, the FLZ’s dimensions for work, finances, leisure activities, marriage, friends, and living conditions. The differences in quality of life and sexuality in the two groups thus appear to be health related rather than dependent on the social situation or living conditions of affected women. Furthermore, because the SF-36’s dimensions on general health were also similar in the two groups, PCOS-specific factors must be responsible for the pronounced reduction in HRQL and sexuality reported here.
Psychological disturbances, evaluated with the SCL-90-R, are considered to be an important factor influencing quality of life. Women with PCOS reported greater psychological disturbances, compared with controls, with significantly elevated global indices (GSI, PSDI, and PST), designed to measure the overall psychological distress and the intensity of symptoms. Secondary analyses controlling for BMI revealed that some of the reported group differences in the SCL-90-R’s scales were attributable to obesity rather than PCOS. However, even after statistically controlling for BMI, patients with PCOS had significantly greater scores in the dimensions of obsessive-compulsive, interpersonal sensitivity, depression, and psychoticism. These problems in socioemotional well-being, particularly symptoms of depression, could very conceivably contribute to an exacerbation of the effects of medical illness. The FLZ demonstrated disease-specific restrictions in the scales of health, self, and sex. Thus, in patients with PCOS, disease-related changes in appearance, irregular or absent menstrual periods, and infertility appear to have a considerable effect on quality of life.
In addition to limitations in emotional well-being, quality of life, and life satisfaction, the diagnosis of PCOS clearly has a negative impact on sexual self-worth and sexual satisfaction, which deserves more attention in clinical practice and research. Although PCOS and control groups were comparable regarding partner status, frequency of sexual intercourse, and sexual thoughts and fantasies, patients with PCOS were significantly less satisfied with their sex life and reported on their impression that their partners were less satisfied, too. In addition, women with PCOS found themselves significantly less sexually attractive, which was significantly associated with the feeling of sexual satisfaction. Disease-related changes in appearance, particularly hirsutism, acne, and obesity, hormonal disturbances, fear of infertility, and psychological distress may contribute to these negative effects on sexual satisfaction and sexual self-worth, possibly by affecting self-esteem and female identity. Although it remains to be determined which of the accompanying clinical symptom(s) of PCOS accounts for the present results, obesity was clearly not the only determinant because statistical control for elevated BMI left the results virtually unchanged.
It should be noted that the interpretation of the current data on frequency of sexual intercourse is limited by the fact that a proportion of participants had no sexual partner and that not all aspects of sexuality were analyzed. Therefore, further work is needed to characterize sexual functions in women with PCOS more precisely, including sexual activity that does not involve intercourse (e.g. masturbation frequency) and to take into account the quality of sexual experiences (e.g. sexual arousal, ability to reach orgasm). It is further important to point out that the present results may not apply to the entire PCOS population. Thirty percent of patients in this study were referred from their gynecologist due to infertility problems, and all patients had previously been diagnosed with PCOS, and thus aware of at least some of the implications of their condition. Therefore, a selection bias and/or effects of self-selection for specialized treatment are likely to have affected the results. This is illustrated by the fact that the percentages of women currently wishing to conceive a child were significantly different between the groups even though they were well matched regarding age, education, and socioeconomic status. Hence, generalizability of the present results is limited because affected women were more likely to be concerned about their medical condition and its long-term consequences.
In conclusion, the present study documents the pronounced psychological and psychosocial problems affecting HRQL of patients with PCOS. Although an effective medical treatment aimed at improving PCOS-related symptoms (especially hirsutism, obesity, menstrual irregularity, and infertility) will also reduce psychological distress and improve sexual self-worth, consideration of both the medical and psychological situation with the availability of an additional psychological counseling and participation in a PCOS self-help group are likely to further improve life satisfaction and coping of affected women.
|
Acknowledgments |
|---|
|
Footnotes |
|---|
Received April 1, 2003.
Accepted August 24, 2003.
|
References |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
This article has been cited by other articles:
 |
|
 |
|
  S. Tan, S. Hahn, S. Benson, O.E. Janssen, T. Dietz, R. Kimmig, J. Hesse-Hussain, K. Mann, M. Schedlowski, P.C. Arck, et al. Psychological implications of infertility in women with polycystic ovary syndrome Hum. Reprod., September 1, 2008; 23(9): 2064 - 2071. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.L. Jones, J.M. Hall, A.H. Balen, and W.L. Ledger Health-related quality of life measurement in women with polycystic ovary syndrome: a systematic review Hum. Reprod. Update, January 1, 2008; 14(1): 15 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Trolle, A. Flyvbjerg, U. Kesmodel, and F.F. Lauszus Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial Hum. Reprod., November 1, 2007; 22(11): 2967 - 2973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Barnard, D. Ferriday, N. Guenther, B. Strauss, A.H. Balen, and L. Dye Quality of life and psychological well being in polycystic ovary syndrome Hum. Reprod., August 1, 2007; 22(8): 2279 - 2286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Legro A 27-Year-Old Woman With a Diagnosis of Polycystic Ovary Syndrome JAMA, February 7, 2007; 297(5): 509 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Banaszewska, L. Pawelczyk, R. Z. Spaczynski, J. Dziura, and A. J. Duleba Effects of Simvastatin and Oral Contraceptive Agent on Polycystic Ovary Syndrome: Prospective, Randomized, Crossover Trial J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 456 - 461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
s. S. Elsenbruch, S. Benson, S. Hahn, and O. E. Janssen Reply: Incorporating qualitative approaches is the path to adequate understanding of the psychosocial impact of polycystic ovary syndrome Hum. Reprod., October 1, 2006; 21(10): 2724 - 2725. [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Himelein and S. S. Thatcher Depression and Body Image among Women with Polycystic Ovary Syndrome J Health Psychol, July 1, 2006; 11(4): 613 - 625. [Abstract] [PDF]
|
|
|
|
|
|
S. Hahn, S. Benson, S. Elsenbruch, K. Pleger, S. Tan, K. Mann, M. Schedlowski, W. B. van Halteren, R. Kimmig, and O. E. Janssen Metformin treatment of polycystic ovary syndrome improves health-related quality-of-life, emotional distress and sexuality Hum. Reprod., July 1, 2006; 21(7): 1925 - 1934. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Elsenbruch, S. Benson, S. Hahn, S. Tan, K. Mann, K. Pleger, R. Kimmig, and O. E. Janssen Determinants of emotional distress in women with polycystic ovary syndrome Hum. Reprod., April 1, 2006; 21(4): 1092 - 1099. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hahn, O. E Janssen, S. Tan, K. Pleger, K. Mann, M. Schedlowski, R. Kimmig, S. Benson, E. Balamitsa, and S. Elsenbruch Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome Eur. J. Endocrinol., December 1, 2005; 153(6): 853 - 860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Urbanek, A. Woodroffe, K. G. Ewens, E. Diamanti-Kandarakis, R. S. Legro, J. F. Strauss III, A. Dunaif, and R. S. Spielman Candidate Gene Region for Polycystic Ovary Syndrome on Chromosome 19p13.2 J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6623 - 6629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.H. Abbott, D.K. Barnett, C.M. Bruns, and D.A. Dumesic Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Hum. Reprod. Update, July 1, 2005; 11(4): 357 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Schmid, S. Kirchengast, E. Vytiska-Binstorfer, and J. Huber Infertility caused by PCOS--health-related quality of life among Austrian and Moslem immigrant women in Austria Hum. Reprod., October 1, 2004; 19(10): 2251 - 2257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 PCOS Confers Decreased Psychosocial Well-Being and Sexual Satisfaction Journal Watch Women's Health, March 10, 2004; 2004(310): 6 - 6. [Full Text]
|
|
|
|
 |
|
 Polycystic Ovary Syndrome, Psychiatric Morbidity, and Quality of Life Journal Watch Psychiatry, January 29, 2004; 2004(129): 5 - 5. [Full Text]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
